These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16536639)

  • 1. The fallacy of amyloid and cognition in Alzheimer's disease.
    Lee HG; Zhu X; Perry G; Smith MA
    Drugs Aging; 2006; 23(2):179. PubMed ID: 16536639
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost.
    Underwood E
    Science; 2015 Jul; 349(6247):464. PubMed ID: 26228122
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is amyloid-β harmful to the brain? Insights from human imaging studies.
    Jagust W
    Brain; 2016 Jan; 139(Pt 1):23-30. PubMed ID: 26614753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Amyloid vasoactivity in Alzheimer's disease.
    Kalaria RN; Hedera P
    Lancet; 1996 May; 347(9013):1492-3. PubMed ID: 8676667
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid + activation = Alzheimer's?
    Jagust W
    Neuron; 2009 Jul; 63(2):141-3. PubMed ID: 19640471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?
    Venkataraman A; Kalk N; Sewell G; W Ritchie C; Lingford-Hughes A
    Alcohol Alcohol; 2017 Mar; 52(2):158. PubMed ID: 28182204
    [No Abstract]   [Full Text] [Related]  

  • 12. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of amyloid beta-protein in Alzheimer's disease.
    Liddell M; Owen MJ
    Lancet; 1992 Oct; 340(8823):851. PubMed ID: 1357270
    [No Abstract]   [Full Text] [Related]  

  • 16. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.
    Almkvist O; Kadir A; Nordberg A
    Neurocase; 2015; 21(6):738-47. PubMed ID: 25494540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apolipoprotein J and Alzheimer's amyloid beta solubility].
    Matsubara E
    Nihon Ronen Igakkai Zasshi; 1999 Feb; 36(2):110-5. PubMed ID: 10363528
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's Disease: It's More Than Aβ.
    Buxbaum JN
    FASEB J; 2017 Jan; 31(1):2-4. PubMed ID: 28049154
    [No Abstract]   [Full Text] [Related]  

  • 19. The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.
    Goudsmit J
    Eur J Epidemiol; 2016 Feb; 31(2):99-105. PubMed ID: 27017509
    [No Abstract]   [Full Text] [Related]  

  • 20. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
    Nordberg A
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.